Vanguard Capital Management’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
Other funds holding INDP
Vanguard Capital Management's INDP Position: Q3 2026 in Review
Vanguard Capital Management increased its Indaptus Therapeutics (INDP) stake by 304% in Q3 2026, buying an estimated $218K and bringing the position to 135,978 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #3744.
Vanguard Capital Management first reported a position in INDP in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold INDP as of Q3 2026.
- Vanguard Capital Management held 135,978 shares of Indaptus Therapeutics worth $313K as of Q3 2026.
- Vanguard Capital Management bought 102,326 Indaptus Therapeutics shares in Q3 2026, an estimated $218K.
- Indaptus Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3744 holding.
- Vanguard Capital Management first reported a position in Indaptus Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 20 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.